Correlation Between Virax Biolabs and Zivo Bioscience
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Zivo Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Zivo Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Zivo Bioscience, you can compare the effects of market volatilities on Virax Biolabs and Zivo Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Zivo Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Zivo Bioscience.
Diversification Opportunities for Virax Biolabs and Zivo Bioscience
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Virax and Zivo is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Zivo Bioscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zivo Bioscience and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Zivo Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zivo Bioscience has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Zivo Bioscience go up and down completely randomly.
Pair Corralation between Virax Biolabs and Zivo Bioscience
If you would invest 181.00 in Zivo Bioscience on August 31, 2024 and sell it today you would earn a total of 0.00 from holding Zivo Bioscience or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 4.55% |
| Values | Daily Returns |
Virax Biolabs Group vs. Zivo Bioscience
Performance |
| Timeline |
| Virax Biolabs Group |
| Zivo Bioscience |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Virax Biolabs and Zivo Bioscience Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Zivo Bioscience
The main advantage of trading using opposite Virax Biolabs and Zivo Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Zivo Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zivo Bioscience will offset losses from the drop in Zivo Bioscience's long position.| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Neurobo Pharmaceuticals |
| Zivo Bioscience vs. RenovoRx | Zivo Bioscience vs. Pasithea Therapeutics Corp | Zivo Bioscience vs. Quoin Pharmaceuticals Ltd | Zivo Bioscience vs. Erasca Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |